By Vox Creative | Updated Dec 12, 2023, 10:00am EST

“One of the main barriers is a lack of healthcare professional confidence in the tools, in their ability to interpret the tools, and in the ability to integrate this type of assessment into their typical workflow because it’s time-consuming and [that time is] not necessarily well reimbursed,” Matthews said.

Feb 11 2023

Disease detection during the earlier stages of AD, when neuronal damage is limited, should allow early intervention and increased therapeutic efficacy.

June 29 2022

Artificial intelligence (AI) has great potential to benefit society, but the technology’s full potential can only be realized if it is representative of the diversity of populations it impacts throughout every step of its development.

By Olga Rukovets | Neurology Today | March 2, 2023

Dr. Apostolova said ongoing efforts are looking into early-onset Alzheimer's, what the genetic causes are for sporadic variants, and new strategies to discover risk factors, which could include artificial intelligence and deep learning techniques.